Sun Pharma And Ranbaxy Laboratories

Rediff.com » News » Sun Pharma And Ranbaxy Laboratories

News for Sun Pharma And Ranbaxy Laboratories

Business

Lessons from the Fortis/Raymond family feuds

'Nothing in this world is permanent. So also in business.''And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.......

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Sun Pharma’s market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013. The country’s leading drug maker......

Daiichi-Ranbaxy row: HC orders attachment of assets

The court also restrained RHC Holdings from operating its bank accounts except for payment of salaries and statutory dues till March 23, the next date of hearing. Image: Malvinder Singh (L), chief......

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Arbitration court rules against former Ranbaxy owners for hiding facts during the 2008 buyout An arbitration court in Singapore has ordered Malvinder Singh and Shivinder Mohan Singh, former owners......

Earnings of Sensex companies: March to be best in 7 quarters

Combined net profit estimated to grow 14.6% year-on-year, against a 5.7% decline in the Dec 2015 quarter Equity investors can expect a better show by the country's top listed companies during the......

Rediff News

Sun Pharma And Ranbaxy Laboratories

News for Sun Pharma And Ranbaxy Laboratories

Lessons from the Fortis/Raymond family feuds

As shares plunge to 5-year low, Sun Pharma promoters poorer by Rs 12,660 crore in 10 days

Daiichi-Ranbaxy row: HC orders attachment of assets

Ranbaxy's Singh brothers told to pay Rs 2,562-crore fine to Daiichi

Earnings of Sensex companies: March to be best in 7 quarters

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS